Picture of Maravai Lifesciences Holdings logo

MRVI — Maravai Lifesciences Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Maravai Lifesciences Reports First Quarter 2022 Financial Results

May 5 (Reuters) - Maravai LifeSciences Holdings Inc
 MRVI.O :
    * MARAVAI LIFESCIENCES REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
    * Q1 REVENUE ROSE 65 PERCENT TO $244.3 MILLION
    * CONTINUES TO PROJECT TOTAL REVENUE FOR 2022 IN RANGE OF
$920.0
MILLION TO $960.0 MILLION
    * ADJUSTED FULLY DILUTED EPS (NON-GAAP) IS NOW EXPECTED TO
BE IN
RANGE OF $1.74 - $1.90 PER SHARE FOR 2022
    * FY2022 EARNINGS PER SHARE VIEW $1.77, REVENUE VIEW $942.1
MILLION -- REFINITIV IBES DATA
    * Q1 REVENUE VIEW $232.3 MILLION -- REFINITIV IBES DATA
    * QTRLY ADJUSTED FULLY DILUTED EPS $0.54
    * Q1 EARNINGS PER SHARE VIEW $0.44 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5yP3MD 
Further company coverage:  MRVI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Maravai Lifesciences Holdings

See all news